
Philips is introducing a new ultrasound system called Alturion following recent marketing clearances in the U.S. and Europe.
The system features AI-powered workflows and is designed for high-volume clinical environments, according to the company. Alturion features a 24-inch monitor and a compact footprint intended to support movement between departments and bedside use. Streamlined workflows are designed to reduce manual adjustments and exam time for high patient volumes, according to the firm.
Alturion includes Elevate Plus, an AI-powered measurement tool for abdominal ultrasound already available on other systems in the Philips ultrasound line. The tool automates measurements and is designed to support reproducibility and reduce variability during exams, the company noted.
The system is part of Philips' connected ultrasound ecosystem, sharing a common user interface and interchangeable transducers with the company's EPIQ Elite and Affiniti ultrasound systems. That compatibility is intended to let sonographers and clinicians use the same transducers across multiple systems, which Philips said can simplify training and support consistent workflows across departments.
Alturion is also compatible with Collaboration Live, Philips' tele-ultrasound platform that allows multiple users to connect remotely for support, training, and consultation, the company noted.















![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)


